ArticleCells2023

Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways.

Dmitri Kamashev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.